Manipulation of amyloid deposition and degradation might become possible in the future by the use of eprodisate in AA amyloidosis, 4'-iodo-4'-deoxydoxorubicin in AL amyloidosis, diflunisal in ATTR ...

Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to ...

While research has determined that there is no association between having AMD and then developing Alzheimer's or dementia, ...

Amvuttra operates via RNA interference (RNAi), a groundbreaking technology that inhibits the production of the TTR protein in ...

Discover how intermittent fasting can help improve sleep, memory, and cognitive function in Alzheimer's patients by ...

However, only two related conditions are associated with the simultaneous presence of Bence Jones proteinuria and heavy albuminuria: renal AL amyloidosis and LCDD. [20] It is not uncommon for ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...